Free Trial

PDS Biotechnology (PDSB) SEC Filings & 10K Form

PDS Biotechnology logo
$1.05 -0.10 (-8.70%)
Closing price 04/3/2025 04:00 PM Eastern
Extended Trading
$1.06 +0.01 (+1.43%)
As of 08:51 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent PDS Biotechnology SEC Filings

DateFilerForm TypeView
03/27/2025
3:31 PM
PDS Biotechnology Corp (Filer)
PDS Biotechnology (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/27/2025
6:35 AM
PDS Biotechnology Corp (Filer)
PDS Biotechnology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/13/2025
7:05 AM
PDS Biotechnology Corp (Filer)
PDS Biotechnology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/07/2025
7:50 AM
PDS Biotechnology Corp (Filer)
PDS Biotechnology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/03/2025
3:45 PM
Glover Stephen C. (Reporting)
PDS Biotechnology Corp (Issuer)
PDS Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/03/2025
3:45 PM
Freitag Gregory Gene (Reporting)
PDS Biotechnology Corp (Issuer)
PDS Biotechnology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/28/2025
5:56 AM
PDS Biotechnology Corp (Filer)
PDS Biotechnology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/28/2025
5:21 AM
PDS Biotechnology Corp (Filer)
PDS Biotechnology (Filer)
Form 424B5
02/26/2025
7:05 AM
PDS Biotechnology Corp (Filer)
PDS Biotechnology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/24/2025
7:06 AM
PDS Biotechnology Corp (Filer)
PDS Biotechnology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/05/2025
7:05 AM
PDS Biotechnology Corp (Filer)
PDS Biotechnology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/14/2024
7:05 AM
PDS Biotechnology Corp (Filer)
PDS Biotechnology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/02/2024
7:05 AM
PDS Biotechnology Corp (Filer)
PDS Biotechnology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/16/2024
6:05 AM
PDS Biotechnology Corp (Filer)
PDS Biotechnology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/13/2024
3:39 PM
PDS Biotechnology Corp (Filer)
PDS Biotechnology (Filer)
Form 424B5
08/13/2024
3:13 PM
PDS Biotechnology Corp (Filer)
PDS Biotechnology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/13/2024
7:00 AM
PDS Biotechnology Corp (Filer)
PDS Biotechnology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/08/2024
7:00 AM
PDS Biotechnology Corp (Filer)
PDS Biotechnology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/07/2024
7:00 AM
PDS Biotechnology Corp (Filer)
PDS Biotechnology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/05/2024
7:00 AM
PDS Biotechnology Corp (Filer)
PDS Biotechnology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/01/2024
6:45 AM
PDS Biotechnology Corp (Filer)
PDS Biotechnology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/12/2024
7:05 AM
PDS Biotechnology Corp (Filer)
PDS Biotechnology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/15/2024
4:16 PM
PDS Biotechnology Corp (Filer)
PDS Biotechnology (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/15/2024
7:00 AM
PDS Biotechnology Corp (Filer)
PDS Biotechnology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/09/2024
6:38 PM
PDS Biotechnology Corp (Filer)
PDS Biotechnology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/08/2024
1:22 PM
BlackRock Inc. (Filed by)
PDS Biotechnology Corp (Subject)
PDS Biotechnology (Subject)
Form SC 13G/A
05/02/2024
3:15 PM
PDS Biotechnology Corp (Issuer)
PDS Biotechnology (Issuer)
Toutain Stephan (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
05/02/2024
3:17 PM
PDS Biotechnology Corp (Issuer)
PDS Biotechnology (Issuer)
Toutain Stephan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/02/2024
5:01 AM
PDS Biotechnology Corp (Filer)
PDS Biotechnology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/29/2024
6:25 AM
PDS Biotechnology Corp (Filer)
PDS Biotechnology (Filer)
Form ARS
04/29/2024
6:15 AM
PDS Biotechnology Corp (Filer)
PDS Biotechnology (Filer)
Form DEFA14A
04/29/2024
6:06 AM
PDS Biotechnology Corp (Filer)
PDS Biotechnology (Filer)
Form DEF 14A
04/18/2024
3:15 PM
PDS Biotechnology Corp (Filer)
PDS Biotechnology (Filer)
Form PRE 14A
(Data available from 1/1/2016 forward)

Remove Ads

Related Companies and Tools


This page (NASDAQ:PDSB) was last updated on 4/4/2025 by MarketBeat.com Staff
From Our Partners